First-Line Treatment of Hormone-Sensitive Metastatic PCa First-Line Treatment of Hormone-Sensitive Metastatic PCa
In addition to standard ADT, which patients with hormone-sensitive metastatic prostate cancer should receive abiraterone, docetaxel, both, or neither?Journal of Clinical Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Docetaxel | Health | Hematology | Hormones | Prostate Cancer | Taxotere